Taysha Gene Therapies (TSHA) Fails to deliver data

Key failure to deliver metrics for Taysha Gene Therapies:

Last SEC data release: 2024-08-30
Last 15 days FTD volume: ₹0.01 M
Last 3 months FTD volume: ₹3.24 M
Last year FTD volume: ₹6.16 M

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Taysha Gene Therapies (TSHA) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Taysha Gene Therapies (TSHA) - since 2020

Volume in USD (price x number of shares), data since 2020

Taysha Gene Therapies (TSHA) Failure to deliver volume, Year over Year

Year	Volume (Price x Shares)	Change
2024	₹3.77 M	-22.23%
2023	₹4.85 M	-68.08%
2022	₹15.2 M	346.84%
2021	₹3.4 M	-30.11%
2020	₹4.86 M

FTD volume in the last 3 months for similar companies or competitors

Company	FTD volume (3months)	FTD volume (1 year)	Country
ORIC Pharmaceuticals ORIC	₹1.44 M	₹6.27 M	🇺🇸 USA

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is receiving financial compensation for Delta App installs.
CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions